Utkarsh Acharya

2.1k total citations
32 papers, 520 citations indexed

About

Utkarsh Acharya is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Utkarsh Acharya has authored 32 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Utkarsh Acharya's work include CAR-T cell therapy research (8 papers), Acute Myeloid Leukemia Research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Utkarsh Acharya is often cited by papers focused on CAR-T cell therapy research (8 papers), Acute Myeloid Leukemia Research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Utkarsh Acharya collaborates with scholars based in United States, Canada and United Kingdom. Utkarsh Acharya's co-authors include Seongseok Yun, Ivo Abraham, Nicole D. Vincelette, Victor Heh, Tzu-Cheg Kao, Lona Mody, Salman Khan, David G. Maloney, Caron A. Jacobson and Roland B. Walter and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Utkarsh Acharya

30 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Utkarsh Acharya United States 13 179 95 91 83 81 32 520
Dieter De Smet Belgium 12 46 0.3× 42 0.4× 30 0.3× 62 0.7× 13 0.2× 38 519
Fangfang Sun China 15 37 0.2× 169 1.8× 26 0.3× 90 1.1× 21 0.3× 65 687
Jennie Y. Law United States 11 86 0.5× 32 0.3× 80 0.9× 27 0.3× 59 0.7× 51 288
Anjali Patwardhan United States 12 14 0.1× 51 0.5× 35 0.4× 48 0.6× 14 0.2× 29 389
Syed Ziauddin A. Zaidi Saudi Arabia 12 40 0.2× 29 0.3× 128 1.4× 50 0.6× 52 0.6× 39 428
Pascal Chaı̈bi France 12 165 0.9× 48 0.5× 147 1.6× 66 0.8× 83 1.0× 33 528
Meike Ressing Germany 11 93 0.5× 21 0.2× 73 0.8× 41 0.5× 40 0.5× 15 376
Andrew J. Klink United States 13 149 0.8× 61 0.6× 136 1.5× 102 1.2× 33 0.4× 61 524
Minyoung Her South Korea 14 73 0.4× 151 1.6× 64 0.7× 50 0.6× 18 0.2× 36 616
Scott A. Soefje United States 8 139 0.8× 53 0.6× 14 0.2× 71 0.9× 19 0.2× 29 369

Countries citing papers authored by Utkarsh Acharya

Since Specialization
Citations

This map shows the geographic impact of Utkarsh Acharya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Utkarsh Acharya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Utkarsh Acharya more than expected).

Fields of papers citing papers by Utkarsh Acharya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Utkarsh Acharya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Utkarsh Acharya. The network helps show where Utkarsh Acharya may publish in the future.

Co-authorship network of co-authors of Utkarsh Acharya

This figure shows the co-authorship network connecting the top 25 collaborators of Utkarsh Acharya. A scholar is included among the top collaborators of Utkarsh Acharya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Utkarsh Acharya. Utkarsh Acharya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Roberts, Daniel A., K. Leahy, Sara Giordano, et al.. (2022). Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the Future. JCO Oncology Practice. 19(6). e927–e934. 5 indexed citations
3.
Acharya, Utkarsh, et al.. (2022). Improving compliance with appropriateness of testing for heparin-induced thrombocytopaenia: a quality improvement report. BMJ Open Quality. 11(3). e001746–e001746. 1 indexed citations
4.
Maurer, Katie, Haesook T. Kim, Utkarsh Acharya, et al.. (2021). COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience. Blood Advances. 5(3). 861–871. 24 indexed citations
5.
Lynch, David T., et al.. (2021). Mantle Cell Lymphoma. StatPearls. 1 indexed citations
6.
Acharya, Utkarsh. (2020). A Case Of Atypical Presentation of Thoracic Osteomyelitis & Paraspinal Abscess. SHILAP Revista de lepidopterología. 11(2). 164–7. 1 indexed citations
7.
Acharya, Utkarsh & Roland B. Walter. (2020). Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML). Cancers. 12(12). 3617–3617. 10 indexed citations
8.
Acharya, Utkarsh, et al.. (2019). Cancer, Malignant Melanoma. StatPearls. 2 indexed citations
9.
Acharya, Utkarsh, Tejaswini Dhawale, Seongseok Yun, et al.. (2019). Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy. Expert Review of Hematology. 12(3). 195–205. 64 indexed citations
10.
Hirayama, Alexandre V., Jordan Gauthier, Kevin A. Hay, et al.. (2018). Efficacy and Toxicity of JCAR014 in Combination with Durvalumab for the Treatment of Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma. Blood. 132(Supplement 1). 1680–1680. 30 indexed citations
11.
Yun, Seongseok, Nicole D. Vincelette, Utkarsh Acharya, & Ivo Abraham. (2016). Risk of Atrial Fibrillation and Bleeding Diathesis Associated With Ibrutinib Treatment: A Systematic Review and Pooled Analysis of Four Randomized Controlled Trials. Clinical Lymphoma Myeloma & Leukemia. 17(1). 31–37.e13. 76 indexed citations
12.
Acharya, Utkarsh, et al.. (2015). Risk factors associated with lower defecation frequency in hospitalized older adults: a case control study. BMC Geriatrics. 15(1). 44–44. 9 indexed citations
13.
Jeter, Joanne & Utkarsh Acharya. (2013). Use of ipilimumab in the treatment of melanoma. Clinical Pharmacology Advances and Applications. 5(Suppl 1). 21–21. 15 indexed citations
14.
Babiker, Hani M., et al.. (2013). Acute Systemic Viral Infection Masquerading as an Infiltrating Lymphoma in an Elderly Patient: A Case Report and Review of the Literature. Case Reports in Medicine. 2013. 1–5. 1 indexed citations
15.
Acharya, Utkarsh, et al.. (2010). Pharmacotherapy and the risk for community-acquired pneumonia. BMC Geriatrics. 10(1). 45–45. 69 indexed citations
16.
Heh, Victor, et al.. (2009). Uses of proton pump inhibitors and serum potassium levels. Pharmacoepidemiology and Drug Safety. 18(9). 865–871. 18 indexed citations
17.
Acharya, Utkarsh, et al.. (2008). Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature. Journal of Hematology & Oncology. 1(1). 26–26. 46 indexed citations
18.
Acharya, Utkarsh, et al.. (2000). ISO 9000 certification in Indian industries: A survey. Total Quality Management. 11(3). 261–266. 47 indexed citations
19.
Acharya, Utkarsh, et al.. (1998). Latex/chlorhexidine‐induced anaphylaxis in pregnancy. Allergy. 53(4). 455–457. 20 indexed citations
20.
McKENZIE, A. W. & Utkarsh Acharya. (1972). THE ORAL CONTRACEPTIVE AND VARIEGATE PORPHYRIA. British Journal of Dermatology. 86(5). 453–457. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026